Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Kadmon

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
The Journal of Urology|October 1, 1982
Prostatic cancer, acid phosphatase, creatine kinase-BB and race: a prospective studyW R Fair, W D Heston, D Kadmon, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 26, 2001
In vivo surgical resection plus adjuvant gene therapy in the treatment of mammary and prostate cancerS W Sukin, M Chhikara, X Zhu, et al.
Prostate Cancer and Prostatic Diseases|July 8, 2009
The role of caveolin-1 in prostate cancer: clinical implicationsT C Thompson, S A Tahir, L Li, et al.
The Journal of Urology|May 8, 2000
Suicide gene therapy toxicity after multiple and repeat injections in patients with localized prostate cancerM Shalev, D Kadmon, B S Teh, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2008
Therapeutic effects of gelatin matrix-embedded IL-12 gene-modified macrophages in a mouse model of residual prostate cancerK Tabata, M Watanabe, K Naruishi, et al.
Clinical & Experimental Metastasis|July 27, 2001
Dietary 4-HPR suppresses the development of bone metastasis in vivo in a mouse model of prostate cancer progressionM R Shaker, G Yang, T L Timme, et al.
Urology|August 11, 1998
Treatment with finasteride preserves usefulness of prostate-specific antigen in the detection of prostate cancer: results of a randomized, double-blind, placebo-controlled clinical trial. PLESS Study Group. Proscar Long-term Efficacy and Safety StudyG L Andriole, H A Guess, J I Epstein, et al.
European Urology|June 22, 2005
Virus specific immune responses after human neoadjuvant adenovirus-mediated suicide gene therapy for prostate cancerR R M van der Linden, B L Haagmans, P Mongiat-Artus, et al.
Human Gene Therapy|November 1, 2001
Prostate-specific antigen response and systemic T cell activation after in situ gene therapy in prostate cancer patients failing radiotherapyB J Miles, M Shalev, E Aguilar-Cordova, et al.
International Journal of Radiation Oncology, Biology, Physics|October 13, 2001
Phase I/II trial evaluating combined radiotherapy and in situ gene therapy with or without hormonal therapy in the treatment of prostate cancer--a preliminary reportB S Teh, E Aguilar-Cordova, K Kernen, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
The Journal of Urology|October 1, 1982
Prostatic cancer, acid phosphatase, creatine kinase-BB and race: a prospective studyW R Fair, W D Heston, D Kadmon, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 26, 2001
In vivo surgical resection plus adjuvant gene therapy in the treatment of mammary and prostate cancerS W Sukin, M Chhikara, X Zhu, et al.
Prostate Cancer and Prostatic Diseases|July 8, 2009
The role of caveolin-1 in prostate cancer: clinical implicationsT C Thompson, S A Tahir, L Li, et al.
The Journal of Urology|May 8, 2000
Suicide gene therapy toxicity after multiple and repeat injections in patients with localized prostate cancerM Shalev, D Kadmon, B S Teh, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2008
Therapeutic effects of gelatin matrix-embedded IL-12 gene-modified macrophages in a mouse model of residual prostate cancerK Tabata, M Watanabe, K Naruishi, et al.
Clinical & Experimental Metastasis|July 27, 2001
Dietary 4-HPR suppresses the development of bone metastasis in vivo in a mouse model of prostate cancer progressionM R Shaker, G Yang, T L Timme, et al.
Urology|August 11, 1998
Treatment with finasteride preserves usefulness of prostate-specific antigen in the detection of prostate cancer: results of a randomized, double-blind, placebo-controlled clinical trial. PLESS Study Group. Proscar Long-term Efficacy and Safety StudyG L Andriole, H A Guess, J I Epstein, et al.
European Urology|June 22, 2005
Virus specific immune responses after human neoadjuvant adenovirus-mediated suicide gene therapy for prostate cancerR R M van der Linden, B L Haagmans, P Mongiat-Artus, et al.
Human Gene Therapy|November 1, 2001
Prostate-specific antigen response and systemic T cell activation after in situ gene therapy in prostate cancer patients failing radiotherapyB J Miles, M Shalev, E Aguilar-Cordova, et al.
International Journal of Radiation Oncology, Biology, Physics|October 13, 2001
Phase I/II trial evaluating combined radiotherapy and in situ gene therapy with or without hormonal therapy in the treatment of prostate cancer--a preliminary reportB S Teh, E Aguilar-Cordova, K Kernen, et al.
Pageof 7